2010
DOI: 10.1155/2011/382137
|View full text |Cite
|
Sign up to set email alerts
|

Determination of Mesalamine Related Impurities from Drug Product by Reversed Phase Validated UPLC Method

Abstract: In the present study gradient reversed-phase UPLC method was developed for simultaneous determination and separation of impurities and degradation products from drug product. The chromatographic separation was performed on acquity UPLC BEH C18 column (50 mm×2.1 mm, 1.7 µm) using gradient elution. Other UPLC parameters which were optimised are flow rate, 0.7 mL/min; detection wavelength, 220 nm; column oven temperature, 40°C and injection volume 7 µL. Stability indicating capability was established by forced de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 21 publications
0
9
0
Order By: Relevance
“…Based on a literature-known UHPLC method for the separation of 5-ASA from six potential impurities within the final drug product, [1] we initiated method development with the evaluation of an aq. phosphate buffer/MeOH system.…”
Section: Methods Developmentmentioning
confidence: 99%
See 3 more Smart Citations
“…Based on a literature-known UHPLC method for the separation of 5-ASA from six potential impurities within the final drug product, [1] we initiated method development with the evaluation of an aq. phosphate buffer/MeOH system.…”
Section: Methods Developmentmentioning
confidence: 99%
“…phosphate buffer/MeOH system. With a total analysis time of 15 min and a different impurity profile, [1] the main objectives were adapting this method for the main analytes occurring within the three-step synthesis, while simultaneously minimizing the analysis time.…”
Section: Methods Developmentmentioning
confidence: 99%
See 2 more Smart Citations
“…[11][12][13][14][15] The drug was also determined by different UV-spectrophotometric, 16) and Vireodt's method. 17) Spectrofluorimetric, 18,19) TLC, 20,21) HPLC, [22][23][24][25] ultra performance liquid chromatography (UPLC) 26,27) and LC-MS 28) were reported for analysis of ME either in single or in combination with other drugs. Only one HPTLC method was published for determination of ME and its degradation products that depended on using toluene-methanol-ethyl acetate (6.5 : 2.5 : 1, v/v/v) as a developing system and scanning at 244 nm.…”
mentioning
confidence: 99%